.Biogen has actually handed back legal rights to a very early Alzheimer's disease system to Denali R...
.Welcome to this week's Chutes & Ladders, our roundup of considerable leadership hirings, firings...
.Vertex's attempt to treat an unusual genetic ailment has actually hit an additional misfortune. The...
.Vir Medical's second-quarter earnings report had not been except significant news. The provider inv...
.Galapagos has paused enrollment in a trial of a BCMA-directed CAR-T cell therapy, pushing the brake...
.After more than thirty years, genetics treatment innovator James Wilson M.D., Ph.D., is leaving beh...
.As biotechs seek to turn a fresh page in August, a minimum of 3 companies have actually dropped per...
.Expert equity capital agency venBio has actually lifted one more half a billion dollars to buy biot...
.Otsuka Pharmaceutical has gotten Boston-based Jnana Therapeutics for $800 thousand so the Eastern b...
.FibroGen is actually significantly restructuring its own organization, giving up 75% of its USA per...